Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Licensing opportunity from LG Chemical: broad-spectrum catechol-substituted cephalosporin

May 4, 1999

Micrologix completes phase I trial for prevention of bloodstream infections

May 3, 1999

NDA filed for first oral neuraminidase inhibitor for the flu

April 30, 1999

New oxazolidinones claimed by Zeneca (AstraZeneca)

April 30, 1999

Chinese investigators develop new antimicrobial agents

April 28, 1999

Pentose and Cangene enter licensing agreement

April 26, 1999

Abbott obtains marketing rights to Meiji cephalosporin in several major markets

April 23, 1999

Immunotherapeutic method of treating viral respiratory disease available from NIH

April 23, 1999

Amoxil cleared for b.i.d. dosing in children

April 22, 1999

Oxazolidinones useful for resistant Gram-positive infections

April 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...